Description
A cannabidiol analog with close structural similarity to O-1918, a selective antagonist of abnormal cannabidiol (Abn-CBD) at the non-CB1/CB2 endothelial receptor; O-1918 does not bind to CB1 or CB2 receptors at concentrations up to 30 µM and inhibits the vasorelaxant effects of Abn-CBD in vitro and in whole animals
Formal name: 5-methyl-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-1,3-benzenediol
Synonyms: CBD-C1|Cannabidiorcin|Cannabidiorcol|Cannabidiorocol|CBDO
Molecular weight: 258.4
CAS: 35482-50-9
Purity: ≥97%
Formulation: A solution in methyl acetate
Product Type|Biochemicals||Research Area|Cardiovascular System|Vasculature|Vasoconstriction||Research Area|Neuroscience|Cannabinoid Research